1-161771484-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_007348.4(ATF6):​c.82+5042T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.491 in 152,132 control chromosomes in the GnomAD database, including 22,502 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.49 ( 22502 hom., cov: 32)

Consequence

ATF6
NM_007348.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.209

Publications

17 publications found
Variant links:
Genes affected
ATF6 (HGNC:791): (activating transcription factor 6) This gene encodes a transcription factor that activates target genes for the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Although it is a transcription factor, this protein is unusual in that it is synthesized as a transmembrane protein that is embedded in the ER. It functions as an ER stress sensor/transducer, and following ER stress-induced proteolysis, it functions as a nuclear transcription factor via a cis-acting ER stress response element (ERSE) that is present in the promoters of genes encoding ER chaperones. This protein has been identified as a survival factor for quiescent but not proliferative squamous carcinoma cells. There have been conflicting reports about the association of polymorphisms in this gene with diabetes in different populations, but another polymorphism has been associated with increased plasma cholesterol levels. This gene is also thought to be a potential therapeutic target for cystic fibrosis. [provided by RefSeq, Aug 2011]
ATF6 Gene-Disease associations (from GenCC):
  • achromatopsia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • ATF6-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • achromatopsia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.658 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_007348.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATF6
NM_007348.4
MANE Select
c.82+5042T>C
intron
N/ANP_031374.2
ATF6
NM_001437597.1
c.82+5042T>C
intron
N/ANP_001424526.1
ATF6
NM_001410890.1
c.82+5042T>C
intron
N/ANP_001397819.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATF6
ENST00000367942.4
TSL:1 MANE Select
c.82+5042T>C
intron
N/AENSP00000356919.3
ATF6
ENST00000681492.1
c.82+5042T>C
intron
N/AENSP00000506139.1
ATF6
ENST00000680688.1
c.82+5042T>C
intron
N/AENSP00000504865.1

Frequencies

GnomAD3 genomes
AF:
0.492
AC:
74770
AN:
152014
Hom.:
22502
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.146
Gnomad AMI
AF:
0.620
Gnomad AMR
AF:
0.474
Gnomad ASJ
AF:
0.687
Gnomad EAS
AF:
0.323
Gnomad SAS
AF:
0.582
Gnomad FIN
AF:
0.722
Gnomad MID
AF:
0.661
Gnomad NFE
AF:
0.663
Gnomad OTH
AF:
0.542
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.491
AC:
74760
AN:
152132
Hom.:
22502
Cov.:
32
AF XY:
0.494
AC XY:
36768
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.146
AC:
6056
AN:
41508
American (AMR)
AF:
0.474
AC:
7243
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.687
AC:
2384
AN:
3468
East Asian (EAS)
AF:
0.324
AC:
1670
AN:
5158
South Asian (SAS)
AF:
0.584
AC:
2815
AN:
4822
European-Finnish (FIN)
AF:
0.722
AC:
7651
AN:
10590
Middle Eastern (MID)
AF:
0.663
AC:
195
AN:
294
European-Non Finnish (NFE)
AF:
0.663
AC:
45047
AN:
67980
Other (OTH)
AF:
0.537
AC:
1136
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1532
3063
4595
6126
7658
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
638
1276
1914
2552
3190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.607
Hom.:
120858
Bravo
AF:
0.457
Asia WGS
AF:
0.417
AC:
1450
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
2.7
DANN
Benign
0.31
PhyloP100
-0.21
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs905594; hg19: chr1-161741274; COSMIC: COSV63406395; API